Cited by 357Neuroendocrine regulation and behaviorAdvanced Drug Delivery SystemsInhalation and Respiratory Drug Delivery

Recommendations for the standardisation of oxytocin nasal administration and guidelines for its reporting in human research

Guastella, Adam J., Hickie, Ian B., McGuinness, Margaret M., Otis, Melissa, Woods, Elizabeth A., Disinger, Hannah M., Chan, Hak-Kim, Chen, Timothy F. +1 more·2013·Psychoneuroendocrinology

Abstract

A series of studies have reported on the salubrious effects of oxytocin nasal spray on social cognition and behavior in humans, across physiology (e.g., eye gaze, heart rate variability), social cognition (e.g., attention, memory, and appraisal), and behavior (e.g., trust, generosity). Findings suggest the potential of oxytocin nasal spray as a treatment for various psychopathologies, including autism and schizophrenia. There are, however, increasing reports of variability of response to oxytocin nasal spray between experiments and individuals. In this review, we provide a summary of factors that influence transmucosal nasal drug delivery, deposition, and their impact on bioavailability. These include variations in anatomy and resultant airflow dynamic, vascularisation, status of blood vessels, mode of spray application, gallenic formulation (including presence of uptake enhancers, control release formulation), and amount and method of administration. These key variables are generally poorly described and controlled in scientific reports, in spite of their potential to alter the course of treatment outcome studies. Based on this review, it should be of no surprise that differences emerge across individuals and experiments when nasal drug delivery methods are employed. We present recommendations for researchers to use when developing and administering the spray, and guidelines for reporting on peptide nasal spray studies in humans. We hope that these recommendations assist in establishing a scientific standard that can improve the rigor and subsequent reliability of reported effects of oxytocin nasal spray in humans.

Integrity signals

Registry

Crossref · 10.1016/j.psyneuen.2012.11.019

Cites

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

The citation lists haven’t been fetched yet

References 111 · Cited by 357

Authors
Guastella, A. J., Hickie, I. B., McGuinness, M. M., Otis, M., Woods, E. A., Disinger, H. M., Chan, H.-K., Chen, T. F., & Banati, R. B.
Affiliations
  • The University of Sydney (AU)
  • Boston University (US)
Corresponding author
Guastella, Adam J.
Venue
Psychoneuroendocrinology
Publisher
Elsevier BV
Published
2013-05
Volume
38
Issue
5
Pages
612-625
ISSN
0306-4530 (ISSN-L)
OpenAlex
W2055559081
Cited by
357
References
111
Citations by year
2026: 13 · 2025: 17 · 2024: 22 · 2023: 18 · 2022: 25 · 2021: 29 · 2020: 33 · 2019: 36 · 2018: 35 · 2017: 35 · 2016: 17 · 2015: 32 · 2014: 29 · 2013: 13
FWCI
35.60
Type
journal article
Language
en
Open access
closed
Locations
  • Psychoneuroendocrinology (publishedVersion)
  • PubMed (publishedVersion)
  • The Australian Nuclear Science and Technology Organisation Institutional Repository (The Australian Nuclear Science and Technology Organisation) (submittedVersion)
Funders
  • NHMRC (623624, 623625, 1043664)
  • ARC Linkage grant (LP110100513)
  • BUPA health foundation grant (2012-00004)
Topics
  • Social Sciences › Psychology › Social Psychology › Neuroendocrine regulation and behavior
  • Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Advanced Drug Delivery Systems
  • Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Inhalation and Respiratory Drug Delivery
Keywords
oxytocin, nasal spray, mucosal drug delivery, bioavailability, reporting guidelines, standardization, social cognition, autism spectrum disorder, schizophrenia, interindividual variability
MeSH terms
Administration, Intranasal, Adsorption, Humans, Human Experimentation, Nasal Mucosa, Nose, Oxytocin, Research Design, Practice Guidelines as Topic, Nasal Sprays

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review